HanAll Biopharma and Daewoong Pharmaceutical Invest in Turn Biotechnologies
Turn has developed a novel cell rejuvenating platform with significant potential for application in an array of age-related diseases
Turn has developed a novel cell rejuvenating platform with significant potential for application in an array of age-related diseases
The joint partnership, powered by Cloudbyz Clinical Research Management Platform and ClinChoice's industry-leading transformation services, will provide an end-to-end clinical research management technology platform and services to customers
This product is indicated for the short-term treatment of a breathing problem (apnea) in premature infants
A comprehensive assessment of the organisational systems for governance, management, operations and consistency in delivered results, this certification is an endorsement of the company's export capabilities and manufacturing prowess
This could be a game-changer for the prevention of the disease; seeing more doses of the life-saving jab reach more girls
The DRX-Compass helps navigate and accelerate towards superb performance with a solution that grows with its customers
The expansion positions Cambrex with the largest and most advanced API facility in the United States
Daewoong Pharmaceutical, HanAll Biopharma join Astellas Venture Management and other VCs in oversubscribed funding round to accelerate Turn Bio's preclinical advances in multiple therapeutic areas
The app serves as a single, integrated, personalized customer platform for da Vinci surgeons
Researchers from the Tel Aviv University successfully engineer the world's first 3D human spinal cord tissue transplant
Subscribe To Our Newsletter & Stay Updated